Latest California Healthline Stories
Blood Transfusions at the Scene Save Lives. But Ambulances Are Rarely Equipped To Do Them.
More than 60,000 people bleed to death every year in the United States. Many of those deaths occur before the patient reaches a trauma center where blood transfusions can be given.
Telehealth Companies Boost Ad Spending While Taking on More Complex Medicine
Telehealth startups including Ro and Nurx are spending millions to promote themselves as easy dispensers of medicines. Some companies offer care for birth control, sexual dysfunction, and more complex conditions, including behavioral health disorders and obesity.
Dentists Are Pulling ‘Healthy’ and Treatable Teeth To Profit From Implants, Experts Warn
Americans are getting dental implants more than ever — and at costs reaching tens of thousands of dollars. Experts worry some dentists have lost sight of the soul of dentistry: preserving and fixing teeth.
Extended-Stay Hotels, a Growing Option for Poor Families, Can Lead to Health Problems for Kids
Extended-stay hotels are often a last resort for low-income families trying to avoid homelessness. But hotel living can lead to — or exacerbate — various physical and mental health issues for children, say advocates for families and researchers who study homelessness.
The Medicare Advantage Influence Machine
New court filings and lobbying reports reveal an industry drive to tamp down critics — and retain billions of dollars in overcharges.
Tennessee Tries To Rein In Ballad’s Hospital Monopoly After Years of Problems
Ballad Health, a 20-hospital system with the nation’s largest state-sanctioned hospital monopoly, serves patients in Tennessee, Virginia, Kentucky, and North Carolina.
The Biden administration set stringent new federal staffing rules. But for years, nursing homes have failed to meet the toughest standards set by states, including California.
The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
Increasingly, Americans pay for the privilege of seeing a doctor. Research shows concierge medicine can further hamper access to care for those who can’t afford the upgrade.
Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge
The FDA told Amgen to test whether a quarter-dose of its lung cancer drug worked as well as the amount recommended on the product label. It did and with fewer side effects. But Amgen is sticking to the higher dose — which earns it an additional $180,000 a year per patient.
Hospitals Cash In on a Private Equity-Backed Trend: Concierge Physician Care
Hospitals are increasingly stretching a velvet rope, offering “concierge service” to an affluent clientele. Critics say the practice exacerbates primary care shortages.